HEI President Dan Greenbaum provided oral testimony on July 17 at a hearing convened by the U.S. Environmental Protection Agency (EPA) in Washington, D.C., on its proposed “Strengthening Transparency in Regulatory Science” rule. His oral comments, and HEI’s longer written comments on the proposed rule, are available below.
Among other points, Greenbaum stated that HEI has a longstanding commitment to the principles being addressed by the EPA proposal: producing science of the highest integrity and quality, with special attention to issues of reproducibility and transparency. The comments draw on that experience to recommend constructive ways forward to enhance transparency and data access, even while ensuring protection of the privacy of medical information of study subjects.
More information about how HEI handles data access and transparency for the studies it funds can be found on the Data Access and Transparency page.